JP2016526535A5 - - Google Patents

Download PDF

Info

Publication number
JP2016526535A5
JP2016526535A5 JP2016519625A JP2016519625A JP2016526535A5 JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5 JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5
Authority
JP
Japan
Prior art keywords
difluoro
substituted
ethynyl
tetrazol
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016519625A
Other languages
English (en)
Japanese (ja)
Other versions
JP6386035B2 (ja
JP2016526535A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/041984 external-priority patent/WO2014201161A1/en
Publication of JP2016526535A publication Critical patent/JP2016526535A/ja
Publication of JP2016526535A5 publication Critical patent/JP2016526535A5/ja
Application granted granted Critical
Publication of JP6386035B2 publication Critical patent/JP6386035B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016519625A 2013-06-12 2014-06-11 金属酵素阻害剤化合物 Expired - Fee Related JP6386035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361834324P 2013-06-12 2013-06-12
US61/834,324 2013-06-12
PCT/US2014/041984 WO2014201161A1 (en) 2013-06-12 2014-06-11 Metalloenzyme inhibitor compounds

Publications (3)

Publication Number Publication Date
JP2016526535A JP2016526535A (ja) 2016-09-05
JP2016526535A5 true JP2016526535A5 (https=) 2017-06-22
JP6386035B2 JP6386035B2 (ja) 2018-09-05

Family

ID=52022749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519625A Expired - Fee Related JP6386035B2 (ja) 2013-06-12 2014-06-11 金属酵素阻害剤化合物

Country Status (9)

Country Link
US (1) US9688671B2 (https=)
EP (1) EP3008051A4 (https=)
JP (1) JP6386035B2 (https=)
KR (1) KR20160018811A (https=)
CN (1) CN105431418B (https=)
AU (1) AU2014278172B2 (https=)
CA (1) CA2915054A1 (https=)
EA (1) EA201690007A1 (https=)
WO (1) WO2014201161A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3351541A1 (en) 2011-12-11 2018-07-25 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
ES2774267T3 (es) * 2012-01-20 2020-07-20 Mycovia Pharmaceuticals Inc Compuestos inhibidores de metaloenzimas
AU2015231226B2 (en) 2014-03-19 2019-04-04 Mycovia Pharmaceuticals, Inc. Antifungal compound process
JP6633539B2 (ja) 2014-03-19 2020-01-22 ダウ アグロサイエンシィズ エルエルシー 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換−ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
ES2800905T3 (es) 2014-03-19 2021-01-05 Mycovia Pharmaceuticals Inc Procedimiento para compuesto antifúngico
CA2942972A1 (en) 2014-03-19 2015-09-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antifungal compound process
BR112016021257B1 (pt) 2014-03-19 2021-03-02 Viamet Pharmaceuticals (NC), Inc. 2-(2,4- difluorofenil-1,1-diflúor-1-(5-substituído-piridin-2-il)-3- (1h-tetrazol-1-il)propan-2-óis e processos para preparação e uso dos mesmos
CA2942231A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
AU2015231275B2 (en) 2014-03-19 2019-03-07 Mycovia Pharmaceuticals, Inc. Antifungal compound process
CA2942936A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
JP6572234B2 (ja) 2014-03-19 2019-09-04 ヴィアメット ファーマスーティカルズ(エヌシー),インコーポレイテッド 抗真菌化合物の調製方法
MA40943A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
MA40940A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
WO2016077375A1 (en) 2014-11-10 2016-05-19 Genentech, Inc. Bromodomain inhibitors and uses thereof
EP3250571B1 (en) * 2015-01-29 2022-11-30 Genentech, Inc. Therapeutic compounds and uses thereof
JP6847458B2 (ja) 2015-09-18 2021-03-24 マイコヴィア ファーマシューティカルズ,インコーポレイテッド 抗真菌化合物のプロセス
KR102240920B1 (ko) 2015-12-30 2021-04-16 브이피에스-3, 엘엘씨 금속 효소 억제 화합물
CN111818928A (zh) 2018-03-05 2020-10-23 艾库斯生物科学有限公司 精氨酸酶抑制剂
EP3873916B8 (en) * 2018-10-29 2025-03-26 Shanghai Synergy Pharmaceutical Sciences, Ltd. Novel dipeptide compounds and uses thereof
ES3034676T3 (en) 2018-11-16 2025-08-21 Arcus Biosciences Inc Inhibitors of arg1 and/or arg2
WO2020263191A1 (en) 2019-06-27 2020-12-30 Nanyang Technological University Compounds having antimalarial activity
CN110885323A (zh) * 2019-12-02 2020-03-17 中国人民解放军第二军医大学 一种三氮唑醇类衍生物、其制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080062876A (ko) 2006-12-29 2008-07-03 주식회사 대웅제약 신규한 항진균성 트리아졸 유도체
AU2011242562B2 (en) * 2010-04-24 2016-10-13 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
WO2012177635A1 (en) * 2011-06-19 2012-12-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
IN2014MN00093A (https=) * 2011-06-19 2015-06-19 Viamet Pharmaceuticals Inc
EA025266B1 (ru) 2011-06-23 2016-12-30 Ваймет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
EP3351541A1 (en) * 2011-12-11 2018-07-25 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds

Similar Documents

Publication Publication Date Title
JP2016526535A5 (https=)
JP6386035B2 (ja) 金属酵素阻害剤化合物
US11247981B2 (en) Metalloenzyme inhibitor compounds
AU2011242562B2 (en) Metalloenzyme inhibitor compounds
US10919874B2 (en) Metalloenzyme inhibitor compounds